These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22378098)

  • 1. Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.
    Kozielewicz D; Karwowska K; Dybowska D; Halota W
    Endokrynol Pol; 2012; 63(1):52-5. PubMed ID: 22378098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Side effect of pegylated-interferon treatment in chronic C hepatitis: agranulocytosis].
    Halász T; Farkas A; Tolvaj G; Horváth G
    Orv Hetil; 2006 Feb; 147(7):321-4. PubMed ID: 17489160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
    Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
    Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine.
    Czarnywojtek A; Waligórska-Stachura J; Szczepanek E; Zgorzalewicz-Stachowiak M; Bereszyńska I; Kurdybacha P; Stangierski A; Harasymczuk J; Florek E; Waśko R; Ruchała M
    Neuro Endocrinol Lett; 2012; 33(3):268-72. PubMed ID: 22635082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-threatening thyrotoxicosis induced by combination therapy with PEG-interferon and ribavirin in chronic hepatitis C.
    Lin YQ; Wang X; Murthy MS; Agarwala S
    Endocr Pract; 2005; 11(2):135-9. PubMed ID: 15901529
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sarcoïdose in patient with chronic hepatitis C treated with pegylated interferon].
    Moudden MK; Ziadi T; Al Bouzidi A; Ouarssani A; Hadri L; El Baaj M
    Rev Pneumol Clin; 2014 Dec; 70(6):362-5. PubMed ID: 25131364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.
    Iacobellis A; Cozzolongo R; Minerva N; Valvano MR; Niro GA; Fontana R; Palmieri O; Ippolito A; Andriulli A
    Dig Liver Dis; 2014 Jul; 46(7):621-4. PubMed ID: 24675038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
    Hu CC; Chien RN
    Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
    Hwang Y; Kim W; Kwon SY; Yu HM; Kim JH; Choe WH
    Korean J Intern Med; 2015 Nov; 30(6):792-800. PubMed ID: 26552454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
    Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
    [No Abstract]   [Full Text] [Related]  

  • 17. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C.
    Klimacka-Nawrot E; Musialik J; Suchecka W; Petelenz M; Hartman M; Lichtański P; Błońska-Fajfrowska B
    Wiad Lek; 2010; 63(4):289-99. PubMed ID: 21608370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
    Slim J; Afridi MS
    Infect Dis Clin North Am; 2012 Dec; 26(4):917-29. PubMed ID: 23083824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    Oiso N; Sato M; Kawada A
    J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?
    Simón-Talero M; Buti M; Esteban R
    J Viral Hepat; 2012 Jan; 19 Suppl 1():14-7. PubMed ID: 22233409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.